BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25292053)

  • 1. Hepatitis C virus prevalence and genotyping among hepatocellular carcinoma patients in Baghdad.
    Al-Kubaisy WA; Obaid KJ; Noor NA; Ibrahim NS; Al-Azawi AA
    Asian Pac J Cancer Prev; 2014; 15(18):7725-30. PubMed ID: 25292053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
    Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
    Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
    Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
    Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
    Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience.
    Idrees M; Rafique S; Rehman I; Akbar H; Yousaf MZ; Butt S; Awan Z; Manzoor S; Akram M; Aftab M; Khubaib B; Riazuddin S
    World J Gastroenterol; 2009 Oct; 15(40):5080-5. PubMed ID: 19860002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level.
    Yates SC; Hafez M; Beld M; Lukashov VV; Hassan Z; Carboni G; Khaled H; McMorrow M; Attia M; Goudsmit J
    Am J Trop Med Hyg; 1999 Apr; 60(4):714-20. PubMed ID: 10348253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal hepatitis C (HCV) infection and Anti-D immunoglobulin therapy: study testing antibodies, RNA and Genotype of HCV in Baghdad.
    Al-Kubaisy W; Daud S; Al-Kubaisi MW; Al-Kubaisi OW; Abdullah NN
    J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3464-3469. PubMed ID: 29656685
    [No Abstract]   [Full Text] [Related]  

  • 9. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
    Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes.
    Widell A; Verbaan H; Wejstål R; Kaczynski J; Kidd-Ljunggren K; Wallerstedt S
    Scand J Infect Dis; 2000; 32(2):147-52. PubMed ID: 10826899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of hepatitis C virus genotypes and viremia levels with development of hepatocellular carcinoma among Japanese.
    Tanaka K; Hirohata T
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):238-48. PubMed ID: 9778916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study.
    Donato F; Tagger A; Chiesa R; Ribero ML; Tomasoni V; Fasola M; Gelatti U; Portera G; Boffetta P; Nardi G
    Hepatology; 1997 Sep; 26(3):579-84. PubMed ID: 9303486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus genotypes and the development of hepatocellular carcinoma.
    Stankovic-Djordjevic D; Djordjevic N; Tasic G; Dinic M; Karanikolic A; Pesic M
    J Dig Dis; 2007 Feb; 8(1):42-7. PubMed ID: 17261134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
    Uemura M; Sasaki Y; Yamada T; Gotoh K; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
    Ann Surg Oncol; 2014 May; 21(5):1719-25. PubMed ID: 24464342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
    El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
    Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.